Leishmania panamensis: Comparative inhibition of nuclear DNA topoisomerase II enzymes from promastigotes and human macrophages reveals anti-parasite selectivity of fluoroquinolones, flavonoids and pentamidine-Reference-Cited by-同舟云学术

Leishmania panamensis: Comparative inhibition of nuclear DNA topoisomerase II enzymes from promastigotes and human macrophages reveals anti-parasite selectivity of fluoroquinolones, flavonoids and pentamidine

Published:2007-08 Issue:4 Volume:116 Page:475-482
ISSN:0014-4894
Container-title:Experimental Parasitology
language:en
Short-container-title:Experimental Parasitology

Author:

Cortázar Tania M.,Coombs Graham H.,Walker John

Publisher

Elsevier BV

Subject

Immunology,General Medicine,Parasitology,Infectious Diseases

Reference50 articles.

1. Topoiosmerase IV catalysis and mechanism of quinolone action;Anderson;Journal of Biological Chemistry,1998

2. Modification of kinetoplast DNA minicircle composition in pentamidine-resistant Leishmania;Basselin;Acta Tropica,1998

3. Alterations in membrane fluidity, lipid metabolism, mitochondrial activity, and lipophosphoglycan expression in pentamidine resistant Leishmania;Basselin;Parasitology Research,1998

4. Resistance to pentamidine in Leishmania mexicana involves exclusion of the drug from the mitochondrion;Basselin;Antimicrobial Agents and Chemotherapy,2002

5. Structure- activity studies of dicationically substituted bis-benzimidazoles against Giardia lamblia: correlation of antigiardial activity with DNA binding affinity and giardial topoisomerase II inhibition;Bell;Antimicrobial Agents and Chemotherapy,1993

Cited by 44 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Ellagic acid‐loaded soy protein isolate self‐assembled particles: Characterization, stability, and antioxidant activity;Journal of Food Science;2023-11-20

2. Molecular Docking for the Development of Alternative Therapies against Leishmaniasis;ECSOC 2023;2023-11-15

3. Molecular-level strategic goals and repressors in Leishmaniasis – Integrated data to accelerate target-based heterocyclic scaffolds;European Journal of Medicinal Chemistry;2023-09

4. Toxoplasma gondii infection: novel emerging therapeutic targets;Expert Opinion on Therapeutic Targets;2023-05-04

5. Target-Based Rational Improvement Strategies and Pitfalls in Leishmania Drug Discovery;Natural Product Based Drug Discovery Against Human Parasites;2023